St. Olavs Hospital clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   PEScreenNor · Screening for Preeclampsia in Norway With Aspirin…PEScreenNor · Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks

   Enrollment closed, study ongoing

   Also in this update: Primary completion date changed from estimate of Dec 2026 to Sep 30, 2026; Study completion pushed from Jun 2027 to Dec 2027

   St. Olavs Hospital·Not applicable· NCT06108947· Registry history of NCT06108947 on ClinicalTrials.gov (opens the registry)

   Updated Oct 6, 2026

2. Minor

   Intranasal Oxytocin · Benzodiazepine Withdrawal: A Pilot RCT

   Trial completed

   Also in this update: Final enrollment: 66 participants (planned 60); Primary completion date changed from estimate of Dec 31, 2025 to Nov 6, 2025

   St. Olavs Hospital·Phase 2· NCT06757517· Registry history of NCT06757517 on ClinicalTrials.gov (opens the registry)

   Updated Sep 28, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.